Grant: Engage Grants Program
Université de Montréal
$25,000.00
Pilot-scale production of a nystatin nanosuspension with improved antifungal efficacy
EF 2014-15
Résumé
Pharmaceutical nanosuspensions can be produced by particle size reduction of drugs. We recentlydemonstrated that a nystatin nanosuspension can improve the topical treatment of oral candidiasis compared tothe regular suspension. This improvement was due to a better coverage and retention time achieved with thesmaller nanoparticles.Nanomilling is a relatively complex technology. It requires the choice of the right formulation andmanufacturing conditions in order to produce a product meeting very strict quality specifications. The criticalquality attributes comprise adequate content assay, minimal degradation products, minimal impurities andadequate particle size. All these quality attributes must be present after production as well as throughout theshelf life of the product.The quality, the efficacy and the safety of nanomilled nystatin will be impacted by the formulation, themanufacturing process and the choice of parameters. A good understanding of these variables is required forthe proper development of an industrial-scale manufacturing process.We propose to study the production of nanomilled nystatin at a pilot-scale and evaluate long term stability ofthe obtained liquid nanosuspensions.
Programme
Engage Grants Program
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
469473-2014
Name nom
Leclair, Grégoire
Department département
Pharmacie, faculté de
Organization id
63
Institution établissement
Université de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2014
Competition year année de concours
2014
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1552
Committee name en
Quebec Internal Decision Committee
Committee name fr
Comité de décision interne pour le Québec
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
1800
Research subject group en
Chemical engineering
Research subject group fr
Génie chimique
Research subject en
Chemical engineering
Research subject fr
Génie chimique
Partie
1
Nb partie
1
Application title
Pilot-scale production of a nystatin nanosuspension with improved antifungal efficacy
Keyword
NSERC
Application summary
Pharmaceutical nanosuspensions can be produced by particle size reduction of drugs. We recentlydemonstrated that a nystatin nanosuspension can improve the topical treatment of oral candidiasis compared tothe regular suspension. This improvement was due to a better coverage and retention time achieved with thesmaller nanoparticles.Nanomilling is a relatively complex technology. It requires the choice of the right formulation andmanufacturing conditions in order to produce a product meeting very strict quality specifications. The criticalquality attributes comprise adequate content assay, minimal degradation products, minimal impurities andadequate particle size. All these quality attributes must be present after production as well as throughout theshelf life of the product.The quality, the efficacy and the safety of nanomilled nystatin will be impacted by the formulation, themanufacturing process and the choice of parameters. A good understanding of these variables is required forthe proper development of an industrial-scale manufacturing process.We propose to study the production of nanomilled nystatin at a pilot-scale and evaluate long term stability ofthe obtained liquid nanosuspensions.